Male patient talking with female physician

GIVE HYPERTENSION PATIENTS A NEW OPTION

HOW DOES RDN HELP REDUCE HIGH BLOOD PRESSURE?

When overactive nerves cause higher sympathetic activity, it can lead to hypertension for many patients. The Medtronic Renal Denervation (RDN) procedure ablates these nerves to reduce sympathetic activity in the renal arteries and lower blood pressure.

EXPLORE RDN
Female Physician Smiling

IS RDN RIGHT FOR YOUR PATIENTS?

Review the European Society of Cardiology (ESC) guidelines for Medtronic renal denervation patients and other resources to determine which of your patients may benefit from RDN.

VIEW PATIENT SELECTION CRITERIA
Play Video This will play a video - Male Doctor Talking to Camera

Dr. Kandzari presents the SPYRAL HTN-ON MED Trial results

WELL TESTED WELL PROVEN

REVIEW CLINICAL DATA

We can lower blood pressure with RDN.

Dr. Michael Burnier, Nephrologist & Hypertension expert

RAISE

EXPECTATIONS

LOWER BLOOD

PRESSURE

EXPLORE PRODUCTS
Symplicity SPYRAL Catheter

WANT TO KNOW MORE ABOUT RDN?

CONTACT US

HYPERTENSION EPIDEMIC IS A GLOBAL HEALTH CRISIS

1 IN 3 ADULTS WORLDWIDE HAS HYPERTENSION1,2,3

Outline of Three People Standing Next to Each Other

COMPLICATIONS OF HYPERTENSION ACCOUNT FOR 9.4 MILLION DEATHS WORLDWIDE EVERY YEAR4

Patient Getting Blood Pressure Measured

NEARLY 50% OF PATIENTS BECOME NON-ADHERENT TO ANTI-HTN MEDICATIONS WITHIN ONE YEAR5

1

Ikeda N, Sapienza D, Guerrero R, et al. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bull World Health Organ. 2014;92:10–19C.

2

Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005:365:217-223.

3

CDC. Vital Signs: Awareness and Treatment of Uncontrolled Hypertension Among Adults — United States, 2003-2010. Morbidity and MMWR. September 7, 2012;61(35):703-709. Available at: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a3.htm. Accessed May 22, 2019.

4

Lim SS, Vos T, Flaxman AD, et el. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Global Burden of Disease Study 2010. Lancet. 2012.

5

Jung O, Gechter JL, Wunder C, et al. Resistant Hypertension? Assessment of adherence by toxicological urine analysis. Hypertension. April 2013;31(4):766-774.

All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company.  For distribution only in markets where the Symplicity Spyral™ multi-electrode renal denervation catheter and Symplicity G3™ renal denervation RF generator have been approved. Not for distribution in the USA, Japan or France.